11P Senescent immune phenotype (SIP) status that predicts resistance to immune checkpoint blockers (ICB) among CMV+ advanced non-small cell lung cancer (aNSCLC) patients is not associated with chronic type I IFN signature

• DOI: 10.1016/j.annonc.2021.10.027
• Publication Date: 2021-12-10T14:08:36Z
• Authors: M. Naigeon; C. de Oliveira; F-X. Danlos; B. Duchemann; P. Saulnier; L. Boselli; J-M. Jouniaux; F. Griscelli; A. Marabelle; L. Lacroix; L. Cassard; B. Besse; N. Chaput
• Keywords: 03 medical and health sciences; 0302 clinical medicine